The Future of Cancer Detection Just Got Smaller: Ultima Genomics' Revolutionary ppmSeq Technology

Ultima Genomics just unveiled groundbreaking data at AACR 2026 showing how their ppmSeq technology can detect circulating tumor DNA at single-digit parts-per-million sensitivity—a game-changer for minimal residual disease monitoring. This breakthrough could transform how oncologists detect cancer recurrence before it becomes clinically apparent.